Senior Manager, Global Medical Oncology, Medical Communications at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Oncology, BiotechnologyIndustries

Requirements

Strong business acumen and ability to interface with market matrix partners
Ability to manage Medical Communications budget
Expertise in communication landscape, HCP preferences, publication and scientific content planning, data disclosure/dissemination
Understanding of therapeutic disease areas
Expertise to support establishment of strong working collaborations with internal and external disease-area experts
Knowledge of Good Publication Practices, BMS standards and policies, and industry standards
Ability to ensure publications are authored, written, and reviewed according to best practices with integrity, quality, and transparency

Responsibilities

Lead across the BMS matrix to develop and deliver strategically aligned medical publications, scientific content, medical information, medical education, training content, and congress presentations
Ensure endorsement of medical communications plans by relevant governance bodies prior to execution, and continuously develop and maintain plans in alignment with scientific landscape, Local Market Medical, Global Medical, and medical market-level strategy
Serve as the Medical Communications point of contact between medical and other matrix partners
Provide medical communications management oversight
Understand communication needs and own the pull-through and execution of the Scientific Narrative, development and execution of functionally integrated publication plan, content plan, and application to the Scientific Communication Platform (SCP)
Serve as a subject matter expert to BMS internal audiences on communication landscape, HCP preferences, publication and scientific content planning, data disclosure/dissemination, and represent BMS scientific communications to external investigators, key authors, and journal editors
Promote and reinforce publication principles among authors and internal stakeholders, ensuring alignment with Good Publication Practices and BMS standards
Ensure collection of insights to deliver high-quality medical communication for impactful customer dialogue
Identify and drive opportunities to enhance processes, tools, operating procedures, and outsourcing strategy for consistent delivery and alignment of standards
Foster collaborative relationships with academic & clinical experts, publishers, medical associations, and other key stakeholder groups; participate in external initiatives to foster trust and respect
Partner with TA Medical Communication Leads, Market Medical, and other stakeholders to assess, plan, and allocate resources (budget, medical writing, biostatistical services) for timely delivery of high-quality outputs

Skills

Medical Communications

Publication Planning

Scientific Content Development

Medical Strategy

Congress Presentations

Medical Education

Scientific Narrative

Business Acumen

Cross-Functional Leadership

Governance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free